Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Trends in and Predictors of Carbapenem Consumption across North American Hospitals: Results from a Multicenter Survey by the MAD-ID Research Network.

Rhodes NJ, Wagner JL, Davis SL, Bosso JA, Goff DA, Rybak MJ, Scheetz MH; MAD-ID Research Network.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00327-19. doi: 10.1128/AAC.00327-19. Print 2019 Jul.

PMID:
31061154
2.

2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy.

Norris AH, Shrestha NK, Allison GM, Keller SC, Bhavan KP, Zurlo JJ, Hersh AL, Gorski LA, Bosso JA, Rathore MH, Arrieta A, Petrak RM, Shah A, Brown RB, Knight SL, Umscheid CA.

Clin Infect Dis. 2019 Jan 1;68(1):1-4. doi: 10.1093/cid/ciy867.

PMID:
30551156
3.

2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy.

Norris AH, Shrestha NK, Allison GM, Keller SC, Bhavan KP, Zurlo JJ, Hersh AL, Gorski LA, Bosso JA, Rathore MH, Arrieta A, Petrak RM, Shah A, Brown RB, Knight SL, Umscheid CA.

Clin Infect Dis. 2019 Jan 1;68(1):e1-e35. doi: 10.1093/cid/ciy745.

PMID:
30423035
4.

In Vitro Activity of Ceftolozane/Tazobactam vs Nonfermenting, Gram-Negative Cystic Fibrosis Isolates.

Forrester JB, Steed LL, Santevecchi BA, Flume P, Palmer-Long GE, Bosso JA.

Open Forum Infect Dis. 2018 Jul 2;5(7):ofy158. doi: 10.1093/ofid/ofy158. eCollection 2018 Jul.

5.

Best Care for Patients Achieved Through Multidisciplinary Stewardship.

Dodds Ashley E, Davis SL, Heil EL, LaPlante KL, Chahine EB, Bosso JA.

Clin Infect Dis. 2018 Oct 30;67(10):1637. doi: 10.1093/cid/ciy392. No abstract available.

PMID:
29767682
6.

Successful Implementation of an Antimicrobial Stewardship Program at an Academic Medical Center.

Bondarenka CM, Bosso JA.

Hosp Pharm. 2017 Jul;52(7):508-513. doi: 10.1177/0018578717721535. Epub 2017 Jul 26.

7.

Intravenous-only or Intravenous Transitioned to Oral Antimicrobials for Enterobacteriaceae-Associated Bacteremic Urinary Tract Infection.

Rieger KL, Bosso JA, MacVane SH, Temple Z, Wahlquist A, Bohm N.

Pharmacotherapy. 2017 Nov;37(11):1479-1483. doi: 10.1002/phar.2024. Epub 2017 Oct 23.

9.

Clinical pathway for moderate to severe acute bacterial skin and skin structure infections from a US perspective: a roundtable discussion.

Bosso JA, Casapao AM, Edwards J, Klinker K, McCoy C, Nicolau DP, Perez KK, Marcarelli A, Dua D.

Hosp Pract (1995). 2016 Oct;44(4):183-189. Epub 2016 Sep 12.

PMID:
27598313
10.

Comparison of Linezolid and Vancomycin for Methicillin-Resistant Staphylococcus aureus Pneumonia: Institutional Implications.

Tong MC, Wisniewski CS, Wolf B, Bosso JA.

Pharmacotherapy. 2016 Jul;36(7):731-9. doi: 10.1002/phar.1771. Epub 2016 Jun 30.

11.

Impact of a Stewardship-Initiated Restriction on Empirical Use of Ciprofloxacin on Nonsusceptibility of Escherichia coli Urinary Isolates to Ciprofloxacin.

O'Brien KA, Zhang J, Mauldin PD, Gomez J, Hurst JM, Sean Boger M, Bosso JA.

Pharmacotherapy. 2015 May;35(5):464-9. doi: 10.1002/phar.1590.

PMID:
26011139
12.

Recommendations for the successful pursuit of scholarship by pharmacy practice faculty members.

Bosso JA, Hastings JK, Speedie MK, Rodriguez de Bittner M.

Am J Pharm Educ. 2015 Feb 17;79(1):04. doi: 10.5688/ajpe79104.

13.

Adverse reactions associated with systemic polymyxin therapy.

Justo JA, Bosso JA.

Pharmacotherapy. 2015 Jan;35(1):28-33. doi: 10.1002/phar.1493. Epub 2014 Sep 30. Review.

PMID:
25266910
14.

Lack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization.

Bosso JA.

Infect Dis Ther. 2014 Jun;3(1):55-9. doi: 10.1007/s40121-014-0028-8. Epub 2014 May 15.

15.

Stable susceptibility to aminoglycosides in an age of low level, institutional use.

Bosso JA, Haines ML, Gomez J.

Infect Dis Ther. 2013 Dec;2(2):209-15. doi: 10.1007/s40121-013-0016-4. Epub 2013 Oct 22.

16.

Comparison of Hospitalwide and Custom Antibiograms for Clinical Isolates of Pseudomonas aeruginosa.

Bosso JA, Sieg A, Mauldin PD.

Hosp Pharm. 2013 Apr;48(4):295-301. doi: 10.1310/hpj4804-295.test.

17.

Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals.

Davis SL, Scheetz MH, Bosso JA, Goff DA, Rybak MJ.

Pharmacotherapy. 2013 Dec;33(12):1256-63. doi: 10.1002/phar.1327. Epub 2013 Jul 29.

PMID:
23897602
18.

Antimicrobial stewardship in the management of community-acquired pneumonia.

Hurst JM, Bosso JA.

Curr Opin Infect Dis. 2013 Apr;26(2):184-8. doi: 10.1097/QCO.0b013e32835d0a8f. Review.

PMID:
23434896
19.

The Economic Impact of Starting, Stopping, and Restarting an Antibiotic Stewardship Program: A 14-Year Experience.

Ullman MA, Parlier GL, Warren JB, Mateo N, Harvey C, Sullivan CJ, Bergsbaken R, Mitropoulos IF, Bosso JA, Rotschafer JC.

Antibiotics (Basel). 2013 Apr 24;2(2):256-64. doi: 10.3390/antibiotics2020256.

20.

AACP strategy for addressing the professional development needs of department chairs.

Schwinghammer TL, Rodriguez TE, Weinstein G, Sorofman BA, Bosso JA, Kerr RA, Haden NK.

Am J Pharm Educ. 2012 Aug 10;76(6):S7. doi: 10.5688/ajpe766S7.

21.

Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial.

Bosso JA, Nappi J, Rudisill C, Wellein M, Bookstaver PB, Swindler J, Mauldin PD.

Antimicrob Agents Chemother. 2011 Dec;55(12):5475-9. doi: 10.1128/AAC.00168-11. Epub 2011 Sep 26.

22.

Application of antimicrobial stewardship to optimise management of community acquired pneumonia.

Bosso JA, Drew RH.

Int J Clin Pract. 2011 Jul;65(7):775-83. doi: 10.1111/j.1742-1241.2011.02704.x. Review.

PMID:
21676120
23.

Antibiotic resistance in Pseudomonas aeruginosa related to quinolone formulary changes: an interrupted time series analysis.

Church EC, Mauldin PD, Bosso JA.

Infect Control Hosp Epidemiol. 2011 Apr;32(4):400-2. doi: 10.1086/659157. No abstract available.

PMID:
21460495
24.

Benchmarking in academic pharmacy departments.

Bosso JA, Chisholm-Burns M, Nappi J, Gubbins PO, Ross LA.

Am J Pharm Educ. 2010 Oct 11;74(8):140.

25.

The association between antibiotic use and resistance: the role of secondary antibiotics.

Bosso JA, Mauldin PD, Salgado CD.

Eur J Clin Microbiol Infect Dis. 2010 Sep;29(9):1125-9. doi: 10.1007/s10096-010-0972-5. Epub 2010 Jun 10.

PMID:
20535624
26.

Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria.

Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA.

Antimicrob Agents Chemother. 2010 Jan;54(1):109-15. doi: 10.1128/AAC.01041-09. Epub 2009 Oct 19.

27.

Recommendations for training and certification for pharmacists practicing, mentoring, and educating in infectious diseases pharmacotherapy.

Ernst EJ, Klepser ME, Bosso JA, Rybak MJ, Hermsen ED, Segarra-Newnham M, Drew RH.

Pharmacotherapy. 2009 Apr;29(4):482-8. doi: 10.1592/phco.29.4.482.

PMID:
19323625
28.

Analysis of an outbreak of Clostridium difficile infection controlled with enhanced infection control measures.

Salgado CD, Mauldin PD, Fogle PJ, Bosso JA.

Am J Infect Control. 2009 Aug;37(6):458-64. doi: 10.1016/j.ajic.2008.11.010. Epub 2009 Feb 25.

PMID:
19243859
29.

Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.

Mauldin PD, Salgado CD, Durkalski VL, Bosso JA.

Ann Pharmacother. 2008 Mar;42(3):317-26. doi: 10.1345/aph.1K501. Epub 2008 Feb 19.

PMID:
18285560
30.
31.

Comments on draft of work force document.

Murphy JE, Saseen JJ, Nappi J, Bosso JA.

Am J Health Syst Pharm. 2006 Sep 1;63(17):1592. No abstract available.

PMID:
16914627
33.

American College of Clinical Pharmacy's vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice.

Murphy JE, Nappi JM, Bosso JA, Saseen JJ, Hemstreet BA, Halloran MA, Spinler SA, Welty TE, Dobesh PP, Chan LN, Garvin CG, Grunwald PE, Kamper CA, Sanoski CA, Witkowski PL; American College of Clinical Pharmacy.

Pharmacotherapy. 2006 May;26(5):722-33. No abstract available.

PMID:
16637798
34.

The antimicrobial armamentarium: evaluating current and future treatment options.

Bosso JA.

Pharmacotherapy. 2005 Oct;25(10 Pt 2):55S-62S. Review.

PMID:
16178676
35.

The impact of antibiotic management on resistance.

Bosso JA.

Pharmacotherapy. 2004 Dec;24(12 Pt 2):224S-31S. Review.

PMID:
15585452
36.

Clinical pharmacy and pharmaceutical care.

Bosso JA.

Pharmacotherapy. 2004 Nov;24(11):1499-500. No abstract available.

PMID:
15537553
37.

Linezolid pharmacokinetics in adult patients with cystic fibrosis.

Bosso JA, Flume PA, Gray SL.

Antimicrob Agents Chemother. 2004 Jan;48(1):281-4.

39.

Assessment of differences in antimicrobial effect determined with two in vitro pharmacodynamic models: impact of surface area to volume ratio.

White RL, Bonapace CR, Friedrich LV, Rybak MJ, Cappelletty DM, Mercier RC, Houlihan HH, Aeschlimann JR, Bosso JA.

Pharmacotherapy. 2003 May;23(5):603-8.

PMID:
12741434
40.

Comparison of methods of interpretation of checkerboard synergy testing.

Bonapace CR, Bosso JA, Friedrich LV, White RL.

Diagn Microbiol Infect Dis. 2002 Dec;44(4):363-6.

PMID:
12543542
41.

Determination of antibiotic effect in an in vitro pharmacodynamic model: comparison with an established animal model of infection.

Bonapace CR, Friedrich LV, Bosso JA, White RL.

Antimicrob Agents Chemother. 2002 Nov;46(11):3574-9.

42.
43.

Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.

White RL, Enzweiler KA, Friedrich LV, Wagner D, Hoban D, Bosso JA.

Diagn Microbiol Infect Dis. 2002 Jul;43(3):207-17.

PMID:
12106954
44.

Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilis.

White RL, Friedrich LV, Manduru M, Mihm LB, Bosso JA.

Diagn Microbiol Infect Dis. 2001 Jan;39(1):39-47.

PMID:
11173190
45.

Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods.

Bonapace CR, White RL, Friedrich LV, Bosso JA.

Diagn Microbiol Infect Dis. 2000 Sep;38(1):43-50.

PMID:
11025183
46.

Assessment of the relationship between antimicrobial usage and susceptibility: differences between the hospital and specific patient-care areas.

White RL, Friedrich LV, Mihm LB, Bosso JA.

Clin Infect Dis. 2000 Jul;31(1):16-23. Epub 2000 Jul 14.

PMID:
10913390
47.

Pharmacokinetics of cefepime in patients with thermal burn injury.

Bonapace CR, White RL, Friedrich LV, Norcross ED, Bosso JA.

Antimicrob Agents Chemother. 1999 Dec;43(12):2848-54.

48.

Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes.

Friedrich LV, White RL, Bosso JA.

Clin Infect Dis. 1999 May;28(5):1017-24.

PMID:
10452628
49.
50.

Added qualifications for pharmacy specialists: another perspective.

Bosso JA, Hardin TC.

Ann Pharmacother. 1997 Dec;31(12):1535-6. No abstract available.

PMID:
9416396

Supplemental Content

Loading ...
Support Center